Case number 1:19-cv-02113
AstraZeneca AB et al v. Aurobindo Pharma USA Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 22, 2021 | 67 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Silver, Daniel) |
| Sep 22, 2021 | 68 | Order (2) Docket Text: SO ORDERED Granting [67] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 9/22/2021. (nms) |
| Sep 22, 2021 | 69 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (Attachments: # (1) Order)(nms) |
| Sep 22, 2021 | 69 | Order (2) |
| Jul 16, 2021 | 65 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Amend the Case Schedule by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Joyce, Alexandra) |
| Jul 16, 2021 | 66 | Order (2) Docket Text: SO ORDERED Granting as modified [65] Stipulation and Proposed Order to Amend the Case Schedule (*Reset Deadlines/Hearings: Fact Discovery completed by 9/24/2021, A 3 day Bench Trial is set to start 8/22/2022, at 8:30 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 7/16/2021. (nms) |
| Jul 8, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney James E. Nealon for Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jun 21, 2021 | 64 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's First Set of Interrogatories to Plaintiffs (Nos. 1-11); and (2) Aurobindo's Second Set of Requests for Production to Plaintiffs (Nos. 3-84) filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| May 28, 2021 | 60 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Manasa Devarala on June 30, 2021 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) |
| May 28, 2021 | 61 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Prince Kumar Devadas on June 28, 2021 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) |
| May 28, 2021 | 62 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rohit Ghan on June 17, 2021 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) |
| May 28, 2021 | 63 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Saravanan Kannusamy on July 2, 2021 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) |
| Dec 2, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Steven J. Moore for Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Nov 24, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [59] MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and Attorney James E. Nealon, filed by Aurobindo Pharma USA Inc.. Signed by Judge Richard G. Andrews on 11/24/2020. (nms) |
| Nov 24, 2020 | 59 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Steven J. Moore and Attorney James E. Nealon - filed by Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| Oct 16, 2020 | 56 | Motion to Amend/Correct (5) Docket Text: Unopposed Motion to Amend the Scheduling Order - filed by Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) Modified on 10/16/2020 (nms). |
| Oct 16, 2020 | 57 | Notice (Other) (3) Docket Text: NOTICE of Change of Firm Affiliation by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc. (Silver, Daniel) |
| Oct 16, 2020 | 58 | Order (5) Docket Text: SO ORDERED Granting (D.I. 75 in 18-cv-2010-RGA; D.I. 56 in 19-cv-2113-RGA; D.I. 87 in 18-cv-2051-RGA) Unopposed MOTION to Amend the Scheduling Order (Reset Deadlines/Hearings: Fact Discovery completed by 7/23/2021, a 3 day Bench Trial is set to start 6/13/2022, at 8:30 AM in Courtroom 6A, A Pretrial Conference is set for 5/27/2022, at 9:00 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 10/16/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Oct 5, 2020 | 55 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's response to Plaintiffs' Second Set of Interrogatories (No. 8); and (2) Aurobindo's response to Plaintiffs' Second Set of Requests for Production (Nos. 62-81) filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Sep 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [54] MOTION for Pro Hac Vice Appearance of Attorney Michael Furrow and April Abele Isaacson, filed by Nektar Therapeutics, RedHill Biopharma Inc., AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 9/15/2020. (nms) |
| Sep 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael E. Furrow for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc., RedHill Biopharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(kmd) |
| Sep 15, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney April Abele Isaacson for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics and RedHill Biopharma Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Sep 14, 2020 | 54 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael Furrow and April Abele Isaacson - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Attachments: # (1) Certifications)(Silver, Daniel) Modified on 9/15/2020 (nms). |
| Sep 14, 2020 | 54 | Certifications for Michael Furrow & April Abele Isaacson (2) |
| Sep 4, 2020 | 53 | Notice of Service (2) Docket Text: NOTICE of Service of (1) Plaintiffs Second Set of Requests for Production to Defendant Aurobindo Pharma Usa Inc. and (2) Plaintiffs Second Set of Interrogatories to Defendant Aurobindo Pharma Usa Inc., filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) Modified on 9/8/2020 (nms). |
| Sep 1, 2020 | 52 | Transcript (23) Docket Text: Official Transcript of Markman Hearing Videoconference held on 08/19/20 before Judge Richard G. Andrews. Court Reporter Heather M. Triozzi,Email: Heather_Triozzi@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 9/22/2020. Redacted Transcript Deadline set for 10/2/2020. Release of Transcript Restriction set for 11/30/2020. (Triozzi, Heather) |
| Aug 19, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 8/19/2020. Counsel for Plaintiffs: D. Silver. Counsel for Defendants: H. Rychlicki, C. Hitch. (Court Reporter Heather Triozzi.) Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA (lak) |
| Aug 7, 2020 | N/A | Remark (0) Docket Text: Remark: The dial-in information for the August 19, 2020 Markman hearing is as follows: 1-202-503-1666 Conference ID: 980866230#. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(lak) |
| Aug 3, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing scheduled for August 19, 2020, will be held using Skype for business. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 8/7/2020. Ordered by Judge Richard G. Andrews on 8/3/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jul 28, 2020 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Objections and Responses to Plaintiffs' 30(b)(6) Deposition Notice filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Jul 15, 2020 | 48 | Joint Claim Construction Brief (30) Docket Text: Joint Claim Construction Brief, filed by RedHill Biopharma Inc., Nektar Therapeutics, AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) Modified on 7/16/2020 (nms). |
| Jul 15, 2020 | 49 | Main Document (4) Docket Text: Joint Appendix re [48] Joint Claim Construction Brief, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Attachments: # (1) Exhibits part 1, # (2) Exhibits part 2, # (3) Exhibits part 3, # (4) Exhibits part 4)(Silver, Daniel) Modified on 7/16/2020 (nms). |
| Jul 15, 2020 | 49 | Exhibit 1-24 (Pt. 1 of 4) (243) |
| Jul 15, 2020 | 49 | Exhibit 1-24 (Pt. 2 of 4) (148) |
| Jul 15, 2020 | 49 | Exhibit 1-24 (Pt. 3 of 4) (189) |
| Jul 15, 2020 | 49 | Exhibit 1-24 (Pt. 4 of 4) (131) |
| Jul 14, 2020 | 47 | Notice of Service (2) Docket Text: NOTICE Of Service of Plaintiffs Objections and Responses to Aurobindos First Set of Requests for Production of Documents and Things (Nos. 12), filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Joyce, Alexandra) Modified on 7/14/2020 (nms). |
| Jul 8, 2020 | 45 | Notice (Other) (2) Docket Text: NOTICE of Joinder to Defendants Apotex and MSN's Joint Sur-Reply Claim Construction Brief by Aurobindo Pharma USA Inc. (Dorsney, Kenneth) |
| Jul 8, 2020 | 46 | Redacted Document (9) Docket Text: REDACTED VERSION of [44] Notice to Take Deposition by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Joyce, Alexandra) |
| Jul 7, 2020 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[44]. (nms) |
| Jun 19, 2020 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's First Set of Requests for Production to Plaintiffs' (Nos. 1-2) filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Jun 18, 2020 | 42 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of (1) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, and RedHill Biopharma Inc.s Second Amended Disclosures Pursuant to the District of Delawares Default Standard for Discovery; (2) AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, and RedHill Biopharma Inc.s Second Amended Rule 26(a) Disclosures; and (3) Plaintiffs Second Supplemental Objections and Responses to Defendants Interrogatory No. 1 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc..(Silver, Daniel) |
| Jun 11, 2020 | 39 | Order (4) Docket Text: SO ORDERED Granting (60 in 18-cv-2010-RGA; 65 in 18-cv-2051-RGA; 37 in 19-cv-2113-RGA) Stipulation and Order to Amend Case Schedule. Signed by Judge Richard G. Andrews on 6/11/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jun 11, 2020 | 40 | Order (3) Docket Text: ORDER Granting (66 in 18-cv-2051-RGA; 61 in 18-cv-2010-RGA; 38 in 19-cv-2113-RGA) MOTION to Join Plaintiff and Amend Case Caption (*RedHill Biopharma Inc. added). Signed by Judge Richard G. Andrews on 6/11/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jun 11, 2020 | 41 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent RedHill Biopharma Ltd. for RedHill Biopharma Inc. filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, RedHill Biopharma Inc.. (Silver, Daniel) |
| Jun 9, 2020 | 37 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order to Amend Case Schedule by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) |
| Jun 9, 2020 | 38 | Main Document (4) Docket Text: MOTION to Join Plaintiff and Amend Case Caption - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Proposed Order, # (2) 7.1.1. Certification)(Silver, Daniel) Modified on 6/10/2020 (nms). |
| Jun 9, 2020 | 38 | Text of Proposed Order (3) |
| Jun 9, 2020 | 38 | Rule 7.1.1. Certification (1) |
| Jun 8, 2020 | 36 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief and Exhibits filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Jun 4, 2020 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's responses to Plaintiffs' First Set of Interrogatories (Nos. 1-7) filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Jun 1, 2020 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Initial Invalidity Contentions filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| May 14, 2020 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's Rule 26(a) Initial Disclosures; and (2) Aurobindo's Paragraph 3 Disclosures filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| May 12, 2020 | 32 | Notice (Other) (2) Docket Text: NOTICE of Joinder to Defendants' Joint Answering Claim Construction Brief by Aurobindo Pharma USA Inc. (Dorsney, Kenneth) |
| May 5, 2020 | 31 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories to Defendant Aurobindo Pharma USA Inc., filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) Modified on 5/6/2020 (nms). |
| May 1, 2020 | 30 | Order (24) Docket Text: SO ORDERED Granting [28] Stipulated Protective Order. Signed by Judge Richard G. Andrews on 5/1/2020. (nms) |
| Apr 30, 2020 | 28 | Stipulation (24) Docket Text: STIPULATED [Proposed] Protective Order Pursuant to Federal Rule of Civil Procedure 26(c), by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Silver, Daniel) Modified on 4/30/2020 (nms). |
| Apr 30, 2020 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Infringement Contentions Pursuant to the District of Delawares Default Standard for Discovery filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Apr 13, 2020 | 26 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Opening Claim Construction Brief and (2) Declaration of Dr. Allan Myerson In Support of Plaintiffs Opening Claim Construction Brief filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Apr 13, 2020 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-61) filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Apr 8, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Angelica H. Nguyen for AstraZeneca AB, AstraZeneca Pharmaceuticals LP and Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(mal) |
| Apr 7, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (61 in 18-cv-2051-RGA; 25 in 19-cv-2113-RGA; 57 in 18-cv-2010-RGA) MOTION for Pro Hac Vice Appearance of Attorney Angelica H. Nguyen, filed by Nektar Therapeutics, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 4/7/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Apr 7, 2020 | 25 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Angelica H. Nguyen - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Certification for Angelica H. Nguyen)(Silver, Daniel) |
| Apr 7, 2020 | 25 | Certification for Angelica H. Nguyen (1) |
| Apr 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [24] STIPULATION TO EXTEND TIME for the substantial completion of document production to May 14, 2020. Signed by Judge Richard G. Andrews on 4/6/2020. (nms) |
| Apr 6, 2020 | 24 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the substantial completion of document production to May 14, 2020 - filed by Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| Apr 1, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (60 in 18-cv-2051-RGA; 56 in 18-cv-2010-RGA; 23 in 19-cv-2113-RGA) Stipulation and Proposed Order for Extension of Time Regarding Claim Construction Briefing. Signed by Judge Richard G. Andrews on 4/1/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Mar 31, 2020 | 23 | Stipulation (4) Docket Text: STIPULATION For Extension of Time Regarding Claim Construction Briefing, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Joyce, Alexandra) Modified on 4/1/2020 (nms). |
| Mar 27, 2020 | 22 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of paragraph 4b disclosures filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Mar 13, 2020 | 21 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production to Defendant Aurobindo Pharma USA Inc. filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Mar 6, 2020 | 20 | Main Document (10) Docket Text: Supplemental Joint Claim Construction Statement, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Appendix C)(Silver, Daniel) Modified on 3/12/2020 (nms). |
| Mar 6, 2020 | 20 | Appendix C (53) |
| Mar 2, 2020 | 19 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and Nektar Therapeutics Section 4.a. Disclosures Pursuant to the District of Delawares Default Standard for Discovery filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Feb 20, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: As a result of the teleconference on 2/20/20, on or before 10/21/20, the parties, though counsel, are to advise of their respective interest in mediation and timing of mediation, with a brief explanation why. Ordered by Judge Mary Pat Thynge on 2/20/20. (cak) |
| Feb 14, 2020 | 17 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aurobindo's Claim Terms for Construction filed by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) |
| Feb 10, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Feb 10, 2020 | 16 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 2/20/2020 at 12:00 Noon Eastern Time with Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 2/10/20. (cak) |
| Feb 3, 2020 | 14 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Referral to Magistrate Judge for Alternative Dispute Resolution by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Joyce, Alexandra) |
| Feb 3, 2020 | 15 | Scheduling Order (2) Docket Text: SO ORDERED re [14] Stipulation and Order Regarding Referral to Magistrate Judge for Alternative Dispute Resolution. Signed by Judge Richard G. Andrews on 2/3/2020. (nms) |
| Jan 28, 2020 | 13 | Order (4) Docket Text: SO ORDERED Granting (D.I. 12 in 19-cv-2113-RGA; D.I. 53 in 18-cv-2051-RGA; D.I. 48 in 18-cv-2010-RGA) Stipulation and Order Regarding Scheduling (*Reset Deadlines: Joint Claim Construction Brief due by 7/15/2020, Fact Discovery completed by 8/28/2020; A Bench Trial is set for 9/20/2021, at 8:30 AM in Courtroom 6A; A Markman Hearing is set for 8/19/2020, at 9:00 AM in Courtroom 6A; A Pretrial Conference is set for 9/10/2021, at 2:00 PM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 1/28/2020. Associated Cases: 1:18-cv-02010-RGA, 1:18-cv-02051-RGA, 1:19-cv-02113-RGA(nms) |
| Jan 22, 2020 | 12 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Dec 19, 2019 | 11 | Answer to Counterclaim (11) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics.(Silver, Daniel) |
| Dec 17, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Aaron P. Maurer for AstraZeneca AB, for AstraZeneca Pharmaceuticals LP, for Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Dec 12, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sumeet P. Dang for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Dec 11, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang, filed by Nektar Therapeutics, AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Richard G. Andrews on 12/11/2019. (nms) |
| Dec 11, 2019 | 10 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jessamyn S. Berniker, Aaron P. Maurer, Sumeet P. Dang - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics. (Attachments: # (1) Certifications)(Silver, Daniel) Modified on 12/11/2019 (nms). |
| Dec 11, 2019 | 10 | Certifications for Jessamyn S. Berniker, Aaron P. Maurer, and Sumeet P. Dang (3) |
| Dec 2, 2019 | 8 | Answer to Complaint (28) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against AstraZeneca AB, AstraZeneca Pharmaceuticals LP, Nektar Therapeutics, by Aurobindo Pharma USA Inc..(Dorsney, Kenneth) Modified on 12/2/2019 (nms). |
| Dec 2, 2019 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) |
| Nov 13, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Nov 11, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, Nektar Therapeutics, AstraZeneca Pharmaceuticals LP. Aurobindo Pharma USA Inc. served on 11/8/2019, answer due 12/2/2019. (Silver, Daniel) |
| Nov 8, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma USA Inc. on 11/8/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (kmd) |
| Nov 8, 2019 | 1 | Main Document (12) Docket Text: COMPLAINT filed against Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2774629.) - filed by AstraZeneca AB, Nektar Therapeutics, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(kmd) |
| Nov 8, 2019 | 1 | Exhibit A (20) |
| Nov 8, 2019 | 1 | Civil Cover Sheet (1) |
| Nov 8, 2019 | 2 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/26/2019. Date of Expiration of Patent: 4/4/2032. Thirty Month Stay Deadline: 3/26/2022. (kmd) |
| Nov 8, 2019 | 3 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (kmd) |
| Nov 8, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,012,469. (kmd) |
| Nov 8, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (kmd) |
| Nov 8, 2019 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Primecap Management Company, Corporate Parent The Vanguard Group, Corporate Parent Fidelity Management and Research LLC for Nektar Therapeutics filed by Nektar Therapeutics. (kmd) |
| Nov 8, 2019 | 1 | Complaint* (1) |
